Suppr超能文献

丝氨酸蛋白酶和金属蛋白酶在人垂体腺瘤及垂体前叶组织中的表达

Expression of serine proteases and metalloproteinases in human pituitary adenomas and anterior pituitary lobe tissue.

作者信息

Knappe Ulrich J, Hagel Christian, Lisboa Björn W, Wilczak Waldemar, Lüdecke Dieter K, Saeger Wolfgang

机构信息

Department of Neurosurgery, Dr.-Horst-Schmidt-Kliniken, Ludwig-Erhard-Strasse 100, 65199, Wiesbaden, Germany.

出版信息

Acta Neuropathol. 2003 Nov;106(5):471-8. doi: 10.1007/s00401-003-0747-5. Epub 2003 Aug 2.

Abstract

Data on the dural invasiveness of pituitary adenomas have been correlated to the expression of matrix metalloproteinases (e.g. MMP-9). Serine proteases have not yet been investigated in human pituitary adenomas. In this study, paraffin-embedded material from 84 human pituitary adenomas (acromegaly n=18, Cushing's disease n=21, prolactinoma n=18, thyroid-stimulating hormone-secreting adenoma n=1, nonsecreting adenoma n=26) and 9 nontumourous anterior pituitary lobes (obtained from patients with prostate cancer) was immunohistochemically analysed for expression of MMP-2, MMP-9, tissue inhibitor of metalloproteinases-2 (TIMP-2), urokinase-type plasminogen activator (uPA), uPA receptor (uPAR), tissue-type plasminogen activator (tPA), plasminogen activator inhibitor-1 (PAI-1), and interleukin-6 (IL-6). Cavernous sinus invasion was determined by assessment of preoperative magnetic resonance imaging and intraoperative inspection (invasive n=50, noninvasive n=34). In pituitary adenomas, reactions were positive (diffuse expression) to MMP-2 (74% of cases), MMP-9 (49%), TIMP-2 (88%), uPA (89%), uPAR (90%), tPA (69%), and PAI-1 (87%). A weak expression of IL-6 was found in 12% of the adenomas. All reactions were positive (focal expression) in every sample of anterior lobe tissue, except for uPA (negative in 3 out of 9 cases), and IL-6 (faintly positive in 5 out of 8 cases). Adenomas showed remarkably greater expression of uPA than anterior lobe tissue (Chi-square P<0.05). Nonsecreting adenomas exhibited a stronger tendency towards overexpression of uPA in invasive tumours when compared to noninvasive adenomas (Chi-square P=0.053). We found no correlation of MMP-9 expression and tumour invasion. TIMP-2 was overexpressed in noninvasive as compared to invasive adenomas (Chi-square P<0.05). The interrelationship between MMPs and serine proteinases in pituitary adenomas remains to be elucidated. From our data, a correlation between IL-6 and an activation of MMP-9 cannot be proven. The uPA-system may, however, play a role in dural invasion of pituitary adenomas.

摘要

垂体腺瘤的硬脑膜侵袭性数据已与基质金属蛋白酶(如MMP-9)的表达相关联。丝氨酸蛋白酶尚未在人类垂体腺瘤中进行研究。在本研究中,对来自84例人类垂体腺瘤(肢端肥大症n = 18、库欣病n = 21、催乳素瘤n = 18、促甲状腺激素分泌腺瘤n = 1、无分泌功能腺瘤n = 26)以及9个非肿瘤性垂体前叶(取自前列腺癌患者)的石蜡包埋材料进行免疫组织化学分析,以检测MMP-2、MMP-9、金属蛋白酶组织抑制剂-2(TIMP-2)、尿激酶型纤溶酶原激活剂(uPA)、uPA受体(uPAR)、组织型纤溶酶原激活剂(tPA)、纤溶酶原激活剂抑制剂-1(PAI-1)和白细胞介素-6(IL-6)的表达。通过术前磁共振成像评估和术中检查确定海绵窦侵袭情况(侵袭性n = 50,非侵袭性n = 34)。在垂体腺瘤中,对MMP-2(74%的病例)、MMP-9(49%)、TIMP-2(88%)、uPA(89%)、uPAR(90%)、tPA(69%)和PAI-1(87%)的反应呈阳性(弥漫性表达)。在12%的腺瘤中发现IL-6表达较弱。除uPA(9例中有3例阴性)和IL-6(8例中有5例弱阳性)外,在每个垂体前叶组织样本中所有反应均呈阳性(局灶性表达)。腺瘤中uPA的表达明显高于垂体前叶组织(卡方检验P<0.05)。与非侵袭性腺瘤相比,无分泌功能腺瘤在侵袭性肿瘤中uPA过表达的趋势更强(卡方检验P = 0.053)。我们发现MMP-9表达与肿瘤侵袭无相关性。与侵袭性腺瘤相比,TIMP-2在非侵袭性腺瘤中过表达(卡方检验P<0.05)。垂体腺瘤中MMPs与丝氨酸蛋白酶之间的相互关系仍有待阐明。根据我们的数据,无法证实IL-6与MMP-9激活之间存在相关性。然而,uPA系统可能在垂体腺瘤的硬脑膜侵袭中起作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验